We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$31B
AUM Growth
+$5.1B
Cap. Flow
+$4.42B
Cap. Flow %
14.26%
Top 10 Hldgs %
15.35%
Holding
1,525
New
241
Increased
776
Reduced
376
Closed
66

Sector Composition

Rank Sector Weight
1 Financials 17.48%
2 Technology 15.7%
3 Healthcare 13.87%
4 Industrials 10.19%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUSA icon
1276
Murphy USA
MUSA
$10.1B
$508K ﹤0.01%
6,855
-80
-1% -$5.6K
USG
1277
DELISTED
Usg
USG
$506K ﹤0.01%
17,440
TCF
1278
DELISTED
TCF Financial Corporation
TCF
$504K ﹤0.01%
31,648
+420
+1% +$6.76K
AMPH icon
1279
Amphastar Pharmaceuticals
AMPH
$850M
$500K ﹤0.01%
+28,000
New +$444K
LPNT
1280
DELISTED
LifePoint Health, Inc.
LPNT
$498K ﹤0.01%
7,422
AGR
1281
DELISTED
Avangrid, Inc.
AGR
$497K ﹤0.01%
11,266
CAA
1282
DELISTED
CalAtlantic Group, Inc.
CAA
$497K ﹤0.01%
14,061
-3,660
-21% -$133K
TDS icon
1283
Telephone and Data Systems
TDS
$3.82B
$496K ﹤0.01%
17,881
-1,160
-6% -$31.9K
ENDP
1284
DELISTED
Endo International plc
ENDP
$496K ﹤0.01%
44,410
+5,550
+14% +$65.2K
SGI
1285
Somnigroup International
SGI
$13.5B
$493K ﹤0.01%
36,956
-720
-2% -$8.49K
IBKR icon
1286
Interactive Brokers
IBKR
$41.5B
$492K ﹤0.01%
52,548
+1,920
+4% +$17K
GHDX
1287
DELISTED
Genomic Health, Inc.
GHDX
$488K ﹤0.01%
+15,000
New +$475K
PBF icon
1288
PBF Energy
PBF
$8.34B
$482K ﹤0.01%
21,648
SKT icon
1289
Tanger
SKT
$4.42B
$481K ﹤0.01%
18,524
QEP
1290
DELISTED
QEP RESOURCES, INC.
QEP
$480K ﹤0.01%
47,574
AVH
1291
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$479K ﹤0.01%
73,623
-12,912
-15% -$91.1K
AMAG
1292
DELISTED
AMAG Pharmaceuticals
AMAG
$478K ﹤0.01%
+26,000
New +$515K
AKAO
1293
DELISTED
Achaogen Inc
AKAO
$478K ﹤0.01%
+22,000
New +$502K
UFS
1294
DELISTED
DOMTAR CORPORATION (New)
UFS
$476K ﹤0.01%
12,397
RVNC
1295
DELISTED
Revance Therapeutics, Inc.
RVNC
$475K ﹤0.01%
+18,000
New +$401K
EGRX
1296
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$473K ﹤0.01%
+6,000
New +$491K
SLGN icon
1297
Silgan Holdings
SLGN
$4.3B
$470K ﹤0.01%
14,780
WLK icon
1298
Westlake Corp
WLK
$10.1B
$470K ﹤0.01%
7,099
-450
-6% -$28.6K
SGMO
1299
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$466K ﹤0.01%
+53,000
New +$340K
SIOX
1300
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$464K ﹤0.01%
+2,500
New +$438K

Similar funds

State of Wisconsin Investment Board's Q2 2017 Portfolio in Review

As of Q2 2017, State of Wisconsin Investment Board held 1,525 positions worth $31B, up 20% from $25.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

State of Wisconsin Investment Board deployed $4.42B of net new capital in Q2 2017, opening 241 new positions and adding to 776 existing holdings. Its largest new stake was Altaba Inc: 1,221,540 shares worth $66.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $64.5M trimmed.

  • State of Wisconsin Investment Board's largest Q2 2017 buy was Altaba Inc: 1,221,540 shares worth $66.5M.
  • State of Wisconsin Investment Board added most to Apple in Q2 2017, an estimated $132M increase.
  • State of Wisconsin Investment Board's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $64.5M.
  • State of Wisconsin Investment Board fully exited State Street SPDR S&P Biotech ETF in Q2 2017, selling an estimated $105M.
  • State of Wisconsin Investment Board's ten largest holdings make up 15% of its $31B portfolio in Q2 2017.
  • State of Wisconsin Investment Board opened 241 new positions and closed 66 in Q2 2017.
  • State of Wisconsin Investment Board's portfolio value rose 20% quarter-over-quarter to $31B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2017, filed 3 Aug 2017.